TY  - GEN
AU  - Pfau,Maximilian
AU  - Fassnacht-Riederle,Heidi
AU  - Becker,Matthias D
AU  - Graf,Nicole
AU  - Michels,Stephan
TI  - Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion
SN  - 1423-0259
PY  - 2016///0419
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Bevacizumab
KW  - Drug Substitution
KW  - Female
KW  - Humans
KW  - Intravitreal Injections
KW  - Macular Edema
KW  - drug therapy
KW  - Male
KW  - Ranibizumab
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Recombinant Fusion Proteins
KW  - Retina
KW  - pathology
KW  - Retinal Vein Occlusion
KW  - complications
KW  - Retrospective Studies
KW  - Tomography, Optical Coherence
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
KW  - drug effects
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1159/000439223
ER  -